Exeptional Ventures

Sector

Health Tech

Investment Date

November 2023

Investment Round

Seed

Current Round

Seed

Unfabled is a consumer health platform that offers sustainable health and wellness products personalized to meet individual needs. They provide curated self-care products for hormonal symptoms, menstrual health, sexual wellness, and more, all in one company

Founders

Hannah Samano

Founder & CEO
 

Linkedin »

Hannah Samano

Founder & CEO
 

Linkedin »

Co-investors

Morgan Stanley

Morgan Stanley is a global financial services firm headquartered in New York City, offering investment banking, wealth management, and investment management services. In 2024, the company reported net revenues of $61.8 billion and net income of $13.4 billion, marking a 50% increase from the previous year.

Founders Factory

Founders Factory is a London-based venture studio and accelerator that co-builds and funds startups across sectors like fintech, health, climate, and deep tech. Founded in 2015 by Brent Hoberman, Henry Lane Fox, and George Northcott, it has supported over 300 startups globally, helping them raise over $1 billion in follow-on funding.

Sequoia

Sequoia Capital is a leading American venture capital firm founded in 1972, known for early investments in companies like Apple, Google, and Airbnb. In 2023, it split into three independent entities: Sequoia Capital (U.S. and Europe), Peak XV Partners (India and Southeast Asia), and HongShan (China), to address operational complexities and regional conflicts.

Reckitt

Reckitt is a British multinational consumer goods company headquartered in Slough, UK. It owns leading brands like Dettol, Durex, Finish, and Enfamil, operating in over 70 countries. In 2024, Reckitt reported net revenues of £14.2 billion and net income of £1.4 billion.

Atomico

Atomico is a London-based European venture capital firm founded in 2006 by Skype co-founder Niklas Zennström. It has invested in over 155 companies, including DeepL, Klarna, and Supercell. In 2024, Atomico raised $1.24 billion across two funds: $485 million for early-stage investments and $754 million for growth-stage companies.